Home » Expertise
» Industries
» Healthcare and Life Sciences » Healthcare and Life Sciences - Publications
The Senate appears likely to reject the proposal to exclude "biological materials" from patentable subject matter in Australia, as Deborah Polites and Richard Hoad explain.
13 Oct 2011
In the recent case between Sanofi-Aventis Australia Pty Ltd and Apotex Pty Ltd [2011] FCA 846, the Federal Court of Australia addressed for the first time the issues of copyright subsistence and infringement in relation to product information documents (PI) for pharmaceutical products.
2 Aug 2011
This issue includes: New arrivals - Some insights into the TGA's risk management approach; Nanotechnology - nano problem or time for Australian business to actively manage potential risks?;
11 Aug 2010
IPAustralia is seeking comment on the implementation of the TRIPS Protocol, which would make compulsory licences for pharmaceutical products easier to grant.
26 May 2010
This issue includes: One for all, and all for one? A unified approach to therapeutic goods promotion; There was movement at the station: the Australian consumer law reforms are being enacted into law; What's up doc? The doctor's duty of care to third parties; European developments: to regulate or not to regulate - that is the question?;
30 Sep 2009
